葡萄牙儿童解除COVID-19限制六个月后肺炎球菌携带及血清型分布
该横断面研究于2022年末在葡萄牙城市地区18个月至6岁日托儿童中开展,采用唾液qPCR检测肺炎球菌携带及血清型分布。584名儿童中34.9%为携带者,PCV13血清型携带率低(除3型7.8%和19F型5.4%),非PCV13血清型以23A、15B/C、23B、11A/D为主。PCV13、PCV15、PCV20的理论覆盖率分别为17.6%、23.0%、46.1%。
要点
- 解除COVID-19限制六个月后,儿童肺炎球菌血清型分布与疫情前大致相似。
- PCV13血清型携带率低,但3型(7.8%)和19F型(5.4%)仍较突出。
- 唾液采样敏感性低于鼻咽拭子,但适用于血清型分布监测。
核心结论
- 解除COVID-19限制六个月后,葡萄牙儿童肺炎球菌血清型分布与疫情前大致相似。
- PCV13血清型携带率低,但3型仍较高,非PCV13血清型稳定存在。
研究设计与样本
- 横断面研究,于2022年末在葡萄牙城市地区日托中心招募18个月至6岁儿童584名。
- 采集唾液样本、疫苗接种记录及人口学/临床数据,采用qPCR检测lytA和piaB基因确定携带状态。
- 对65种血清型/血清群进行分子血清分型,并新设计验证了5、7A/F、9A/V、9N/L、17F和33A/F/37型引物/探针。
主要发现
- 584名儿童中34.9%为肺炎球菌携带者。
- PCV13血清型携带率低,除3型(7.8%)和19F型(5.4%)外。
- 非PCV13血清型中最常见为23A(10.8%)、15B/C(10.3%)、23B(9.8%)和11A/D(9.3%)。
- 4-6岁儿童携带PCV13血清型的可能性是18-24个月儿童的近15倍(p=0.012)。
关键数值与推荐
- PCV13、PCV15和PCV20的理论覆盖率分别为17.6%、23.0%和46.1%。
- 唾液采样对总体携带率估计的敏感性低于鼻咽拭子,但特别适用于评估血清型分布。
临床怎么用
- 在鼻咽拭子采集依从性低的情况下,唾液采样可作为肺炎球菌血清型携带监测的实用、有效且非侵入性的替代方法。
- 监测中需关注3型等PCV13血清型的持续携带及非PCV13血清型的分布变化。
局限性
- 唾液采样对总体肺炎球菌携带率估计的敏感性低于鼻咽拭子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus pneumoniae remains a major cause of infectious disease globally, with young children serving as key reservoirs for transmission. This study evaluated pneumococcal carriage and serotype distribution among young children in Portugal, six months after the lifting of COVID-19 public health measures and seven years after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the National Immunization Plan. A cross-sectional study was conducted in late 2022 among children aged 18 months to 6 years attending day-care centers in an urban region. Saliva samples, vaccination records, and demographic/clinical data were collected. Pneumococcal carriage was determined by qPCR targeting lytA and piaB genes. Molecular serotyping of 65 serotypes/serogroups was performed. New primers/probes were designed and validated for serotypes/serogroups 5, 7A/F, 9A/V, 9N/L, 17F and 33A/F/37, expanding the range of serotypes that could be reliably identified. Among 584 children, 34.9% were pneumococcal carriers. Carriage of PCV13 serotypes was low, except for serotypes 3 (7.8%) and 19F (5.4%). Among non-PCV13 serotypes, 23A (10.8%), 15B/C (10.3%), 23B (9.8%), and 11A/D (9.3%) were the most frequent. Theoretical coverage of PCV13, PCV15, and PCV20 was 17.6%, 23.0%, and 46.1%, respectively. Children 4-6 years were nearly 15 times more likely to carry PCV13 serotypes than those aged 18-24 months (p = 0.012). Six months post-COVID-19 restrictions lifting, serotype distribution largely resembled the pre-pandemic period. Although saliva sampling had lower sensitivity than nasopharyngeal swabbing for estimating overall pneumococcal carriage prevalence, it was particularly useful to assess serotype distribution. Importantly, in a context where nasopharyngeal swabbing was met with reluctance, saliva sampling emerged as a practical, effective, and non-invasive alternative for pneumococcal serotype carriage surveillance.
引用
- Almeida ST, Paulo AC, Simões AS, et al. Pneumococcal carriage and serotype distribution in Portuguese children six months after the lifting of COVID-19 restrictions: rise in serotype 3 amid stable non-vaccine serotypes. Vaccine. 2026. PMID: 41633308. doi:10.1016/j.vaccine.2026.128294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。